Movement Alert|Docusign Rises 5.05% in Regular Trading, Q2 Earnings Beat Across All Metrics as Multiple Banks Raise Price Targets

Market Focus
22 hours ago

On September 15, Docusign rose 5.05% in regular trading, trading at $73.265/share, with turnover of approximately $106 million.

On the news front, the company recently reported FY2027 Q2 results that exceeded consensus across all key metrics. Revenue came in at $875.7 million, up 9.4% year-over-year and beating estimates by $8.54 million. Adjusted EPS reached $1.16, surpassing the $1.09 consensus by 6.4%. The company simultaneously raised its full-year revenue guidance to $3.499 billion-$3.507 billion and lifted its IAM business ARR mix target to 18%-19%, reflecting accelerating adoption of its Intelligent Agreement Management platform. Deal sizes continued expanding, with customers exceeding $300,000 in annual contract value growing 14% to 1,296, marking a second consecutive quarter of double-digit growth.

Following the earnings release, multiple investment banks raised their price targets: Morgan Stanley to $75, Piper Sandler to $75, RBC to $70, and BofA to $64. Additionally, the company announced it will open its MCP server to all AI agents on September 30, integrating with Claude, ChatGPT, Gemini, and other major platforms, further reinforcing its AI ecosystem strategy.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10